Skip to content

Modif. of Emit Cad Disopyramide Assay

by Syva Co.

510(k) K833623

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK833623 Date8 Dec 1983ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KLR
Device Class
Class II
Regulation
21 CFR Part 862.3555
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an enzyme immunoassay for lidocaine, classified under regulation number 862.3555 and product code KLR. It is a modified version of the EMIT CAD Disopyramide Assay, designed for the detection of disopyramide in clinical specimens using enzyme immunoassay technology.

The assay is intended for use in clinical toxicology settings and is supplied as a reagent system for in vitro diagnostic use. It received FDA 510(k) clearance (K833623) on December 8, 1983, as a substantially equivalent device to a legally marketed predicate. The device is for prescription use only and is manufactured by Syva Co. in McHenry, Illinois, United States.

Other devices from Syva Co.

See all devices from Syva Co. →

Questions

AI-generated answers, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the MODIF. OF EMIT CAD DISOPYRAMIDE ASSAY used for?

    This device is an enzyme immunoassay designed for the detection of disopyramide in clinical specimens, intended for use in clinical toxicology settings as an in vitro diagnostic reagent system.

  • How is the MODIF. OF EMIT CAD DISOPYRAMIDE ASSAY supplied and what is its format?

    The assay is supplied as a reagent system for in vitro diagnostic use, meaning it includes the necessary components to perform the enzyme immunoassay test for disopyramide detection in a laboratory setting.

  • Is the MODIF. OF EMIT CAD DISOPYRAMIDE ASSAY intended for single-use or reuse?

    As an in vitro diagnostic reagent system, the assay is designed for single-use per test run, with reagents consumed during the enzyme immunoassay process to detect disopyramide in clinical specimens.